Lista de obras -

Activating mutations in c-KIT and PDGFRalpha are exclusively found in gastrointestinal stromal tumors and not in other tumors overexpressing these imatinib mesylate target genes

artículo científico publicado en 2005

Anticancer drug resistance induced by disruption of the Saccharomyces cerevisiae NPR2 gene: a novel component involved in cisplatin- and doxorubicin-provoked cell kill

artículo científico publicado en 2003

Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib

artículo científico publicado en 2006

Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps

artículo científico publicado en 2005

Determination of topotecan in human whole blood and unwashed erythrocytes by high-performance liquid chromatography

artículo científico publicado en 2002

Does P-glycoprotein play a role in anticancer drug pharmacokinetics?

artículo científico publicado en 2000

Effect of ABCG2 genotype on the oral bioavailability of topotecan

artículo científico publicado en 2005

Evaluation of an alternate dosing strategy for cisplatin in patients with extreme body surface area values

artículo científico publicado en 2006

Functional cloning of drug resistance genes from retroviral cDNA libraries

artículo científico publicado en 2003

Functional screen for genes responsible for tamoxifen resistance in human breast cancer cells

artículo científico publicado en 2006

Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump

artículo científico publicado en 2004

Impact of Body-Size Measures on Irinotecan Clearance: Alternative Dosing Recommendations ⬇️

artículo científico publicado el 1 de enero de 2002

Impaired cisplatin influx in an A2780 mutant cell line: evidence for a putative, cis-configuration-specific, platinum influx transporter

artículo científico publicado en 2006

Inactivation of the Saccharomyces cerevisiae SKY1 gene induces a specific modification of the yeast anticancer drug sensitivity profile accompanied by a mutator phenotype

artículo científico publicado en 2002

Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel

artículo científico publicado en 2002

Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.

artículo científico publicado en 2005

Molecular profiling of platinum resistant ovarian cancer.

artículo científico publicado en 2006

Pharmacokinetic resistance to imatinib mesylate: role of the ABC drug pumps ABCG2 (BCRP) and ABCB1 (MDR1) in the oral bioavailability of imatinib

artículo científico publicado en 2004

Preclinical evaluation of alternative pharmaceutical delivery vehicles for paclitaxel

artículo científico publicado en 2002

RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.

artículo científico publicado en 2003

Randomized cross-over evaluation of body-surface area-based dosing versus flat-fixed dosing of paclitaxel

artículo científico publicado en 2003

Red blood cells: a neglected compartment in topotecan pharmacokinetic analysis

artículo científico publicado en 2003

Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1.

artículo científico publicado en 2004

Structural identification and biological activity of 7-methyl-10,11-ethylenedioxy-20(S)-camptothecin, a photodegradant of lurtotecan

artículo científico publicado en 2002

Lista de obras de

Activating mutations in c-KIT and PDGFRalpha are exclusively found in gastrointestinal stromal tumors and not in other tumors overexpressing these imatinib mesylate target genes

Anticancer drug resistance induced by disruption of the Saccharomyces cerevisiae NPR2 gene: a novel component involved in cisplatin- and doxorubicin-provoked cell kill

Association of enzyme and transporter genotypes with the pharmacokinetics of imatinib

Chronic imatinib mesylate exposure leads to reduced intracellular drug accumulation by induction of the ABCG2 (BCRP) and ABCB1 (MDR1) drug transport pumps

Determination of topotecan in human whole blood and unwashed erythrocytes by high-performance liquid chromatography

Does P-glycoprotein play a role in anticancer drug pharmacokinetics?

Effect of ABCG2 genotype on the oral bioavailability of topotecan

Evaluation of an alternate dosing strategy for cisplatin in patients with extreme body surface area values

Functional cloning of drug resistance genes from retroviral cDNA libraries

Functional screen for genes responsible for tamoxifen resistance in human breast cancer cells

Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump

Impact of Body-Size Measures on Irinotecan Clearance: Alternative Dosing Recommendations ⬇️

Impaired cisplatin influx in an A2780 mutant cell line: evidence for a putative, cis-configuration-specific, platinum influx transporter

Inactivation of the Saccharomyces cerevisiae SKY1 gene induces a specific modification of the yeast anticancer drug sensitivity profile accompanied by a mutator phenotype

Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel

Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.

Molecular profiling of platinum resistant ovarian cancer.

Pharmacokinetic resistance to imatinib mesylate: role of the ABC drug pumps ABCG2 (BCRP) and ABCB1 (MDR1) in the oral bioavailability of imatinib

Preclinical evaluation of alternative pharmaceutical delivery vehicles for paclitaxel

RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response.

Randomized cross-over evaluation of body-surface area-based dosing versus flat-fixed dosing of paclitaxel

Red blood cells: a neglected compartment in topotecan pharmacokinetic analysis

Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1.

Structural identification and biological activity of 7-methyl-10,11-ethylenedioxy-20(S)-camptothecin, a photodegradant of lurtotecan